The medical care of immunocompromised patients with COVID-19 infection causes major
hurdles in the management of these patients in clinical practice. However, poor responses to …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
have become a major concern in the containment of current pandemic. The variants …

Background While Covid-19 monoclonal antibody therapies (Mab) have been available in
the outpatient setting for over a year and a half, little is known about the impact of emerging …

Vaccination and administration of monoclonal antibody cocktails are effective tools to control
the progression of infectious diseases and to terminate pandemics such as COVID-19 …

As we are moving into the Flu season, a raise in infection with a new variant of SARS-CoV-2
is noted. The Food and Drug Administration and the Centers for Disease Control (CDC) …

The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
the cause of the coronavirus disease (COVID-19) pandemic. As of August 2021, more than …

COVID-19 is a life-threatening respiratory disease triggered by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). It has been considered a pandemic viral infection …

ABSTRACT Coronavirus disease 2019 (COVID-19) was declared as pandemic on March
11th 2020 by the world health organization (WHO). Vaccination is for preventing COVID-19 …

Monoclonal antibodies (mAbs) are emerging as safe and effective therapeutics against
SARS-CoV-2. However, variant strains of SARS-CoV-2 have evolved, with early studies …

Background Anti–SARS-CoV-2 monoclonal antibodies have been shown to reduce severe
COVID-19 in high-risk ambulatory patients. Methods This operations study at 3 affiliated …